tolazamide has been researched along with Hyperglycemia, Postprandial in 2 studies
Tolazamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.
tolazamide : An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.
Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In these NIDDM patients, exposure of pancreatic beta-cells to sustained levels of sulfonylureas induces a reversible state of refractoriness to acute stimulation with sufonylureas but not to another secretagogue." | 1.27 | Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. ( Karam, JH; Nolte, MS; Salamon, E; Sanz, N, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karam, JH | 1 |
| Sanz, N | 1 |
| Salamon, E | 1 |
| Nolte, MS | 1 |
| Turtle, JR | 1 |
2 other studies available for tolazamide and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM.
Topics: Aged; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hyperglycemia; Is | 1986 |
Glucose and insulin secretory response patterns following diet and tolazamide therapy in diabetes.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism, Inborn Errors; Diabetes Mellitus; Diet, Diabetic; Glu | 1970 |